HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.

AuthorsN A Mark Estes 3rd, Richard J Kovacs, Aaron L Baggish, Robert J Myerburg, American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology
JournalCirculation (Circulation) Vol. 132 Issue 22 Pg. e330-3 (Dec 01 2015) ISSN: 1524-4539 [Electronic] United States
PMID26621651 (Publication Type: Journal Article, Review)
Chemical References
  • Performance-Enhancing Substances
Topics
  • Advisory Committees (standards)
  • American Heart Association
  • Athletes
  • Cardiology (methods, standards)
  • Cardiovascular Abnormalities (diagnosis, epidemiology)
  • Humans
  • Performance-Enhancing Substances (adverse effects, analysis, standards)
  • Practice Guidelines as Topic (standards)
  • United States (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: